Source: BioPortfolio

NBE Therapeutics: Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBETherapeutics

Basel Switzerland November 15 2018 B3C newswire NBE Therapeutics AG a biopharmaceutical company developing nextgeneration immunestimulatory antibodydrug conjugates iADCs for improved cancer therapy today announces the appointment of Dr. Anthony Tolcher ...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Bertrand Damour's photo - CEO of NBE-Therapeutics

CEO

Bertrand Damour

CEO Approval Rating

90/100

NBE Therapeutics is a biotechnology company that develops and commercializes antibody-drug conjugates for the treatment of cancer. Read more